Topical retinoids and cutaneous biology

Clinical and Experimental Dermatology

Volumn 21, Issue 1, 1996, Pages 1-10

  Craven, N M ^a   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN; RETINOIC ACID; RETINOID;

ACNE VULGARIS; ANTINEOPLASTIC ACTIVITY; HUMAN; PIGMENT DISORDER; PRIORITY JOURNAL; PSORIASIS; REVIEW; SKIN CANCER; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTINEOPLASTIC AGENTS; DERMATOLOGIC AGENTS; HUMANS; MICE; NUCLEAR PROTEINS; RATS; RECEPTORS, RETINOIC ACID; RETINOIDS; SKIN; SKIN DISEASES;

EID: 0029889479     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.1996.tb00001.x     Document Type: Review

References (141)

1. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 1925; 42: 753-77.
2. Frazier CN, Hu C-K. Cutaneous lesions associated with a deficiency in vitamin A in man. Arch Intern Med 1931; 48: 507-14.
3. Straumfjord JV. Lesions of vitamin A deficiency. Northwest Med 1942; 41: 229-33.
4. Weinstein GD, Nigra TP, Pochi PE et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol 1991; 127: 659-65.
5. Olsen EA, Katz HI, Levine N et al. Tretinoin emollient cream: A new therapy for photodamaged skin. J Am Acad Dermatol 1992; 26: 215-24.
6. Bollag W, Ott F. Vitamin A acid in benign and malignant epithelial tumours of the skin. Acta Derm Venereol (Stockh) 1975; 55 (Suppl. 74): 163-6.
7. Lippman SM, Meyskens FL. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmac Ther 1989; 40: 107-22.
8. Fry L, MacDonald A, McMinn RMH. Effect of retinoic acid in psoriasis. Br J Dermatol 1970; 83: 391-6.
9. Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA et al. Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 1994; 30: 581-90.
10. Marks R. New indications for topical retinoids. In: Marks R, Cunliffe WJ, eds. Skin Therapy. London: Martin Dunitz Ltd, 1994: 62-8
11. Lehmann JM, Jong L, Fanjul A et al. Retinoids selective for retinoid X receptor response pathways. Science 1992; 258: 1944-6.
12. Fanjul A, Dawson MI, Hobbs PD et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 1994; 372: 107-11.
13. McKenzie RM, Hellwege DM, McGregor ML et al. Separation and identification of geometric isomers of retinoic acid and methyl retinoate. J Chromatogr 1978; 155: 379-87.
14. Takashima V, Nakajima T, Washitake M et al. Stability of retinol analogs. VIII. Pyrolysis and photolysis of retinoic acid in aqueous ethanolic solution. Chem Pharm Bull 1979; 27: 12-22.
15. Lehman PA, Franz TJ. Percutaneous absorption of retinoic acid in man. J Invest Dermatol 1989; 92: 468.
16. Lehman PA, Malany AM. Evidence for percutaneous absorption of isotretinoin from the photo-isomerization of topical tretinoin. J Invest Dermatol 1989; 93: 595-9.
17. Schaefer H, Zesch A. Penetration of vitamin A acid into human skin. Acta Derm Venereol (Stockh) 1975; 55 (Suppl. 74): 50-5.
18. Lehman PA, Slattery JT, Franz TJ. Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose. J Invest Dermatol 1988; 91: 56-61.
19. Schaefer H. Penetration and percutaneous absorption of topical retinoids. Skin Pharmacol 1993; 6 (Suppl. 1): 17-23.
20. Ong DE, Chytil F. Cellular retinoic acid-binding protein from rat testis. J Biol Chem 1978; 253: 4551-4.
21. Giguère V, Lyn S, Yip P et al. Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein. Proc Natl Acad Sci USA 1990; 87: 6233-7.
22. Åström A, Tavakkol A, Pettersson U et al. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 1991; 266: 17662-6.
23. Ong DE, Newcomer ME, Chytil F. Cellular retinoid binding proteins. In: Sporn MB, Roberts AM, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. New York: Raven Press Ltd, 1994: 283-317.
24. Fiorella PD, Napoli JL. Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. J Biol Chem 1991; 266: 16572-9.
25. Sanquer S, Gilchrest BA. Characterization of human cellular retinoic acid-binding proteins-I and -II: ligand binding affinities and distribution in skin. Arch Biochem Biophys 1994; 311: 86-94.
26. Eller MS, Oleksiak MF, McQuaid TJ et al. The molecular cloning and expression of two CRABP cDNAs from human skin. Exp Cell Res 1992; 199: 328-36.
27. Busch C, Siegenthaler G, Vahlquist A et al. Expression of cellular retinoid-binding proteins during normal and abnormal epidermal differentiation. J Invest Dermatol 1992; 99: 795-802.
28. Elder JT, Cromie MA, Griffiths CEM et al. Stimulus-selective induction of CRABP-II mRNA: a marker for retinoic acid action in human skin. J Invest Dermatol 1993; 100: 356-9.
29. Åström A, Pettersson U, Chambon P, Voorhees JJ. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing. J Biol Chem 1994; 269: 22334-9.
30. Fawcett D, Pasceri P, Fraser R et al. Postaxial polydactyly in forelimbs of CRABP-II mutant mice. Development 1995; 121: 671-9.
31. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50.
32. Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624-9.
33. Brand N, Petkovich M, Krust A et al. Identification of a second human retinoic acid receptor. Nature 1988; 332: 850-3.
34. Benbrook D, Lernhardt K, Pfahl M. A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 1988; 333: 669-72.
35. Krust A, Kastner P, Petkovich M et al. A third human retinoic acid receptor, hRAR-γ. Proc Natl Acad Sci USA 1989; 86: 5310-14.
36. Mangelsdorf DJ, Borgmeyer U, Heyman RA et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329-44.
37. Heyman RA, Mangelsdorf DJ, Dyck JA et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397-406.
38. Kastner P, Krust A, Mendelsohn C et al. Murine isoforms of retinoic acid receptor γ with specific patterns of expression. Proc Natl Acad Sci USA 1990; 87: 2700-4.
39. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889-95.
40. Wang L-H, Tsai SY, Cook RG et al. COUP transcription factor is a member of the steroid receptor superfamily. Nature 1989; 340: 163-6.
41. Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 1988; 4: 309-14.
42. Lee MS, Kliewer SA, Provencal J et al. Structure of the retinoid X receptor DNA binding domain: a helix required for homodimeric DNA binding. Science 1993; 260: 1117-21.
43. Bourguet W, Ruff M, Chambon P et al. Crystal structure of the ligand-bind domain of the human nuclear receptor RXR-a. Nature 1995; 375: 377-82.
44. Nagpal S, Saunders M, Kastner P et al. Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 1992; 70: 1007-19.
45. Mader S, Leroy P, Chen J-Y, Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements. J Biol Chem 1993; 268: 591-600.
46. Zhang X-K, Hoffmann B, Tran PB-V et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid receptors. Nature 1992; 355: 441-6.
47. 3 signalling. Nature 1992; 355: 446-9.
48. Mader S, Chen J-Y, Chen Z et al. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J 1993; 12: 5029-41.
49. Zhang X-K, Lehmann J, Hoffman B et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 1992; 358: 587-91.
50. Bedo G, Santisteban P, Aranda A. Retinoic acid regulates growth hormone gene expression. Nature 1989; 339: 231-4.
51. Schule R, Rangarajan P, Yang N et al. Retinoic acid is a negative regulator of AP-1 responsive genes. Proc Natl Acad Sci USA 1991; 88: 6092-6.
52. Pfahl M. Signal transduction by retinoid receptors. Skin Pharmacol 1993; 6 (Suppl. 1): 8-16.
53. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds. The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. New York: Raven Press Ltd, 1994; 319-49.
54. Elder JT, Fisher GJ, Zhang Q-Y et al. Retinoic acid receptor gene expression in human skin. J Invest Dermatol 1991; 96: 425-33.
55. Fisher GJ, Talwar HS, Xiao J-H et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 1994; 269: 20629-35.
56. Li E, Sucov HM, Lee K-F et al. Normal development and growth of mice carrying a targeted disruption of the α1 retinoic acid receptor gene. Proc Natl Acad Sci USA 1993; 90: 1590-4.
57. Lohnes D, Kastner P, Dierich A et al. Function of retinoic acid receptor γ in the mouse. Cell 1993; 73: 643-58.
58. Lufkin T, Lohnes D, Mark M et al. High postnatal lethality and testis degeneration in retinoic acid receptor α mutant mice. Proc Natl Acad Sci USA 1993; 90: 7225-9.
59. Andersen B, Rosenfeld MG. New wrinkles in retinoids. Nature 1995; 374: 118-19.
60. Kastner P, Grondona JM, Mark M et al. Genetic analysis of RXRα developmental function: convergence of RXR and RAR signalling pathways in heart and eye morphogenesis. Cell 1994; 78: 987-1003.
61. Sucov HM, Dyson E, Gumeringer CL et al. RXRα mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994; 8: 1007-18.
62. Saitou M, Sugai S, Tanaka T et al. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 1995; 374: 159-62.
63. Imakado S, Bickenbach JR, Bundman DS et al. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 1995; 9: 317-29.
64. Tickle C, Alberts BM, Wolpert L, Lee J. Local application of retinoic acid to the limb bud mimics the action of the polarizing region. Nature 1982; 296: 564-5.
65. Thaller C, Eichcle G. Identification and spatial distribution of retinoids in the developing chick limb bud. Nature 1987; 327: 625-8.
66. Riddle RD, Johnson RL, Laufer E, Tabin C. Sonic hedgehog mediates the polarizing activity of the ZPA. Cell 1993; 75: 1401-16.
67. Lammer EJ, Chen DT, Hoar RM et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837-41.
68. Sporn MB, Dunlop NM, Newton DL, Smith JM. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976; 35: 1332-8.
69. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 1978; 15: 393-403.
70. Wang S-Y, LaRosa GJ, Gudas LJ. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells. Dev Biol 1985; 107: 75-86.
71. Haussler M, Sidell N, Kelly M et al. Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines. Proc Natl Acad Sci USA 1983; 80: 5525-9.
72. Meyskens FL, Fuller BB. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res 1980; 40: 2194-6.
73. Lacroix A, Lippman ME. Binding of retinoids to human breast cancer cell lines and their effects on cell growth. J Clin Invest 1980; 65: 586-91.
74. Dion LD, Blalock JE, Gifford GE. Retinoic acid and the restoration of anchorage dependent growth to transformed mammalian cells. Exp Cell Res 1978; 117: 15-22.
75. Breitman TR, Selonick SE, Collins S. Induction of differentiation of the human promyelocytic leukaemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-40.
76. Huang M-E, Ye Y-C, Chai J-R et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-72.
77. Warrell RP, Frankel SR, Miller WH et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med 1991; 324: 1385-93.
78. de Thé H, Chomienne C, Lanotte M et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor o gene to a novel transcribed locus. Nature 1990; 347: 558-61.
79. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577-80.
80. Zhu J, Shi X-G, Chu H-Y et al. Effect of retinoic acid isomers on proliferation, differentiation and PML relocalization in the APL cell line NB4. Leukemia 1995; 9: 302-9.
81. Lotan R, Xu X-C, Lippman SM et al. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995; 332: 1405-10.
82. Hong WK, Lippman SM, Itri LM et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990; 323: 795-801.
83. Dejean A, Bougueleret L, Grzeschik K-H, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986; 322: 70-2.
84. Verma AK. Biochemical mechanism of modulation of skin carcinogenesis by retinoids. In: Orfanos CE, Braun-Falco O, Farber EM et al., eds. Retinoids: Advances in Basic Research and Therapy. New York: Springer-Verlag, 1981: 117-31.
85. Li X-Y, Aström A, Duell EA et al. Retinoic acid antagonizes basal as well as coal tar and glucocorticoid-induced cytochrome P4501A1 expression in human skin. Carcinogenesis 1995; 16: 519-24.
86. Yuspa SH, Harris CC. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res 1974; 86: 95-105.
87. Fuchs E, Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 1981; 25: 617-25.
88. Green H, Watt FM. Regulation by vitamin A of envelope cross-linking in cultured keratinocytes derived from different human epithelia. Mol Cell Biol 1982; 2: 1115-17.
89. Roop DR, Huitfeldt H, Kilkenny A, Yuspa SH. Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation 1987; 35: 143-50.
90. Hohl D, Lichti U, Breitkreutz D et al. Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol 1991; 96: 414-18.
91. Varani J, Perone P, Griffiths CEM et al. All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. J Clin Invest 1994; 94: 1747-56.
92. Bhawan J, Gonzalez-Serva A, Nehal K et al. Effects of tretinoin on photodamaged skin. A histologic study. Arch Dermatol 1991; 127: 666-72. (Erratum. Arch Dermatol 1991; 127: 1382).
93. Gendimenico GJ, Mezick JA. Pharmacological effects of retinoids on skin cells. Skin Pharmacol 1993; 6 (Suppl. 1): 24-34.
94. Rosenthal DS, Griffiths CEM, Yuspa SH et al. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin and keratins 6 and 13 but not keratins 1, 10 and 14. J Invest Dermatol 1992; 98: 343-50.
95. Landthaler M, Kummermehr J, Wagner A et al. Effects of 13-cis retinoic acid on sebaceous glands in humans. In: Orfanos CE, Braun-Falco O, Farber EM et al., eds. Retinoids: Advances in Basic Research and Therapy. New York: Springer-Verlag, 1981: 259-66.
96. Rafal ES, Griffiths CEM, Ditre CM et al. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage. N Engl J Med 1992; 326: 368-74.
97. Griffiths CEM, Goldfarb MT, Finkel LJ et al. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial. J Am Acad Dermatol 1994; 30: 76-84.
98. Ortonne J-P. Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies. Br J Dermatol 1992; 127 (Suppl. 41): 43-7.
99. Orlow SJ, Chakraborty AK, Pawelek JM. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J Invest Dermatol 1990; 94: 461-4.
100. Talwar HS, Griffiths CEM, Fisher GJ et al. Differential regulation of tyrosinase activity in skin of white and black individuals in vivo by topical retinoic acid. J Invest Dermatol 1993; 100: 800-5.
101. Ho KK, Halliday GM, Barnetson RS. Topical retinoic acid augments ultraviolet light-induced melanogenesis. Melanoma Res 1992; 2: 41-5.
102. Straumfjord JV. Vitamin A: its effect on acne. Northwest Med 1943; 42: 219-25.
103. Kligman AM, Fulton JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 1969; 99: 469-76.
104. Plewig G, Braun-Falco O. Kinetics of epidermis and adnexa following vitamin A acid in the human. Acta Derm Venereol (Stockh) 1975; 55 (Suppl. 74): 87-98.
105. Chalker DK, Lesher JL, Smith JG et al. Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation. J Am Acad Dermatol 1987; 17: 251-4.
106. Plewig G, Ruhfus A, Klovekorn W. Sebum suppression after topical application of retinoids (arotinoid and isotretinoin). J Invest Dermatol 1983; 80: 357.
107. Bernard BA. Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol 1993; 6 (Suppl. 1): 61-9.
108. Griffiths CEM, Elder JT, Bernard BA et al. Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol 1993; 101: 325-8.
109. Griffiths CEM. The clinical identification and quantification of photodamage. Br J Dermatol 1992; 127 (Suppl. 41): 37-42.
110. Smith JG, Davidson EA, Sams WM, Clark RD. Alterations in human dermal connective tissue with age and chronic sun damage. J Invest Dermatol 1962; 39: 347-50.
111. Kligman AM. Early destructive effect of sunlight on human skin. JAMA 1969; 210: 2377-80.
112. Kligman AM, Lavker RM. Cutaneous aging: the differences between intrinsic aging and photoaging. J Cut Aging Cosmet Dematol 1988; 1: 5-12.
113. Sendagorta K, Lesiewicz J, Armstrong RB. Topical isotretinoin for photodamaged skin. J Am Acad Dermatol 1992; 27: S15-18.
114. Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol 1986; 15: 836-59.
115. Weiss JS, Ellis CN, Headington JT et al. Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled study. JAMA 1988; 259: 527-32. (Errata. JAMA 1988; 259: 3274 and 1988; 260: 926).
116. Griffiths CEM, Finkel LJ, Tranfaglia MG et al. An in vivo experimental model for effects of topical retinoic acid in human skin. Br J Dermatol 1993; 129: 389-94.
117. Chen S, Kiss I, Tramposch KM. Effects of all-trans retinoic acid on UVB-irradiated and non-irradiated hairless mouse skin. J Invest Dermatol 1992; 98: 248-54.
118. Kligman LH, Chen HD, Kligman AM. Topical retinoic acid enhances the repair of ultraviolet damaged dermal connective tissue. Conn Tis Res 1984; 12: 139-50.
119. Bryce GF, Bogdan NJ, Brown CC. Retinoic acids promote the repair of the dermal damage and the effacement of wrinkles in the UVB-irradiated hairless mouse. J Invest Dermatol 1981; 91: 175-80.
120. Schwartz E, Cruickshank FA, Mezick JA, Kligman LH. Topical all-trans retinoic acid stimulates collagen synthesis in vivo. J Invest Dermatol 1991; 96: 975-8.
121. Griffiths CEM, Russman AN, Majumdar G et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993; 329: 530-5.
122. Clark SD, Kobayashi DK, Welgus HG. Regulation of the expression of tissue inhihitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 1987; 80: 1280-8.
123. Robinson TA, Kligman A. Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil. Br J Dermatol 1975; 92: 703-6.
124. Goldberg LH, Hsu SH, Alcalay J. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinoma in basal cell nevus syndrome. J Am Acad Dermatol 1989; 21: 144-5.
125. Kraemer KH, DiGiovanna JJ, Moshell AN et al. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633-7.
126. Edwards L, Jaffe P. The effect of topical tretinoin on dysplastic nevi. Arch Dermatol 1990; 126: 494-9.
127. Levine N, Meyskens FL. Topical vitamin-A-acid therapy for cutaneous metastatic melanoma. Lancet 1980; ii: 224-6.
128. Meyskens FL Jr, Edwards L, Levine NS. Role of topical tretinoin in melanoma and dysplastic nevi. J Am Acad Dermatol 1986; 15: 822-5.
129. Griffiths CEM, Finkel LJ, Ditre CM et al. Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled clinical trial. Br J Dermatol 1993; 129: 415-21.
130. Kimbrough-Green CK, Griffiths CEM, Finkel LJ et al. Topical retinoic acid (tretinoin) for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-33.
131. Pathak MA, Kitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 1986; 15: 894-9.
132. Bulengo-Ransby SM, Griffiths CEM, Kimbrough-Green CK et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 1993; 328: 1438-43.
133. Orfanos CE, Schmidt HW, Mahrle G et al. Retinoic acid in psoriasis: its value for topical therapy with and without corticosteroids. Br J Dermatol 1973; 88: 167-82.
134. Haas AA, Arndt KA. Selected therapeutic applications of topical tretinoin. J Am Acad Dermatol 1986; 15: 870-7.
135. Epstein JH. Chemicals and photocarcinogenesis. Aust J Dermatol 1977; 18: 57-61.
136. Forbes PD, Urbach F, Davies RE. Enhancement of experimental photocarcinogenesis by topical retinoic acid. Cancer Lett 1979; 7: 85-90.
137. Epstein JH. Photocarcinogenesis and topical retinoids. In: Marks R, ed. Retinoids in Cutaneous Malignancy. Oxford: Blackwell Scientific Publications, 1991: 171-82.
138. Worobec SM, Wong FGA, Tolman EL et al. Percutaneous absorption of 3H-tretinoin in normal volunteers. J Invest Dermatol 1991; 96: 574A.
139. Chiang TC. Gas chromatographic-mass spectrometric assay for low levels of retinoic acid in human blood. J Chromatogr 1980; 182: 535-40.
140. Jick SS, Terris BZ, Jick H. First trimester topical tretinoin and congenital disorders. Lancet 1993; 341: 1181-2.
141. Alberts B, Bray D, Lewis J et al. Cell signaling. In: Alberts B, Bray D, Lewis J et al., eds. Molecular Biology of the Cell, 3rd edn. New York: Garland Publishing Inc., 1994: 721-85.